Zur operativen Therapie der peripheren arteriellen Verschlusskrankheit

Die chirurgische Therapie der peripheren arteriellen Verschlusserkrankung konzentriert sich neben der direkten Wiederherstellung der Femoralisbifurkation auf die periphere Bypassanlage, vor allem bei der chronischen amputationsbedrohenden Ischämie. Diese Methoden können mit vor- und nachgeschalteten endovaskulären Eingriffen in Form eines Hybrideingriffs kombiniert werden. Operative und endovaskuläre Eingriffe sind als komplementär zu betrachten.

Abstract

The surgical treatment of peripheral arterial occlusive disease focuses not only on the direct restoration of the femoral bifurcation but also on the peripheral bypass, especially in the case of chronic amputation-threatening ischemia. Comprehensive imaging is indispensable for planning surgical therapy. The local reconstruction of the femoral bifurcation offers very good long-term results and can be easily combined with endovascular methods. The peripheral bypass is the central pillar of surgical therapy, especially in CLTI. Autologous vein should always be the first-choice material. It delivers good long-term results in every position. Prosthetic material is only used if there is no vein and should be combined with autologous veins in the crural and pedal area if possible. The technical limit for a bypass system lies in the pedal arteries and their branches. These methods can be combined with upstream and downstream endovascular interventions in the form of a hybrid intervention. Surgical and endovascular interventions are to be considered as complementary.

Kernaussagen

• Zur Planung der operativen Therapie ist eine umfassende Bildgebung unverzichtbar.

• Die lokale Rekonstruktion der Femoralisbifurkation bietet sehr gute Langzeitergebnisse und ist gut mit endovaskulären Methoden kombinierbar.

• Der periphere Bypass ist die zentrale Säule der chirurgischen Therapie, vor allem bei der CLTI.

• Eine autologe Vene sollte immer Material der 1. Wahl sein. Sie liefert in jeder Position gute Langzeitergebnisse.

• Prothesenmaterial kommt nur bei fehlender Vene zur Anwendung und sollte im kruralen und pedalen Bereich nach Möglichkeit mit autologer Vene kombiniert werden.

• Die technische Grenze für eine Bypassanlage liegt an den pedalen Arterien und ihren Ästen.

Schlüsselwörter

chirurgische Therapie - peripheren arteriellen Verschlusskrankheit - Amputationsbedrohung - Femoralisbifurkation - Bypasschirurgie

Keywords

surgical therapy - peripheral arterial disease - amputation threat - femoral bifurcation - bypass surgery

Publication History

Article published online:
27 September 2023

• Literatur

• 1 Noronen K, Soderstrom M, Kouhia S. et al. Bovine pericardial patch: A good alternative in femoral angioplasty. J Vasc Surg 2023; 77: 225-230 DOI: 10.1016/j.jvs.2022.08.010.
• 2 Hashimoto T, Yamamoto S, Kimura M. et al. Long-Term Outcomes following Common Femoral Endarterectomy. J Clin Med 2022; 11 (22) 6873 DOI: 10.3390/jcm11226873.
• 3 Hoffmann-Wieker CM, Ronellenfitsch U, Rebelo A. et al. Open Surgical Thrombendarterectomy Versus Endovascular Treatment in Occlusive Processes of the Femoral Artery Bifurcation. Dtsch Arztebl Int 2022; 119: 803-809 DOI: 10.3238/arztebl.m2022.0331.
• 4 Taurino M, Persiani F, Ficarelli R. et al. The Role of the Profundoplasty in the Modern Management of Patient with Peripheral Vascular Disease. Ann Vasc Surg 2017; 45: 16-21 DOI: 10.1016/j.avsg.2017.05.018.
• 5 Diehm N, Savolainen H, Mahler F. et al. Does deep femoral artery revascularization as an isolated procedure play a role in chronic critical limb ischemia?. J Endovasc Ther 2004; 11: 119-124
• 6 Piazza M, Ricotta 2nd JJ, Bower TC. et al. Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease. J Vasc Surg 2011; 54: 402-411 DOI: 10.1016/j.jvs.2011.01.027.
• 7 Gabrielli R, Rosati MS, Vitale S. et al. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions. J Vasc Surg 2012; 56: 1598-1605 DOI: 10.1016/j.jvs.2012.06.081.
• 8 Gisbertz SS, Tutein Nolthenius RP, de Borst GJ. et al. Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: medium-term results of a randomized controlled trial (the REVAS trial). Ann Vasc Surg 2010; 24: 1015-1023 DOI: 10.1016/j.avsg.2010.03.022.
• 9 Saaya S, Osipova O, Gostev A. et al. A prospective randomized trial on endovascular recanalization with stenting versus remote endarterectomy for the superficial femoral artery total occlusive lesions. J Vasc Surg 2022; 76: 158-164 DOI: 10.1016/j.jvs.2022.02.019.
• 10 Aboyans V, Ricco JB, Bartelink MEL. et al. Editor’s Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018; 55: 305-368 DOI: 10.1016/j.ejvs.2017.07.018.
• 11 Conte MS, Bradbury AW, Kolh P. et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 2019; 69: 3S-125S e140 DOI: 10.1016/j.jvs.2019.02.016.
• 12 Eugster T, Marti R, Gurke L. et al. Ten years after arterial bypass surgery for claudication: venous bypass is the primary procedure for TASC C and D lesions. World J Surg 2011; 35: 2328-2331 DOI: 10.1007/s00268-011-1237-x.
• 13 Arvela E, Soderstrom M, Alback A. et al. Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia. J Vasc Surg 2010; 52: 616-623 DOI: 10.1016/j.jvs.2010.04.013.
• 14 Vauclair F, Haller C, Marques-Vidal P. et al. Infrainguinal bypass for peripheral arterial occlusive disease: when arms save legs. Eur J Vasc Endovasc Surg 2012; 43: 48-53 DOI: 10.1016/j.ejvs.2011.08.007.
• 15 Linni K, Mader N, Aspalter M. et al. Ultrasonic vein mapping prior to infrainguinal autogenous bypass grafting reduces postoperative infections and readmissions. J Vasc Surg 2012; 56: 126-132 DOI: 10.1016/j.jvs.2011.10.135.
• 16 Lindholt JS, Houlind K, Gottschalksen B. et al. Five-year outcomes following a randomized trial of femorofemoral and femoropopliteal bypass grafting with heparin-bonded or standard polytetrafluoroethylene grafts. Br J Surg 2016; 103: 1300-1305 DOI: 10.1002/bjs.10246.
• 17 Neufang A, Duenschede F, Espinola-Klein C. et al. Contemporary results with the biosynthetic glutaraldehyde denatured ovine collagen graft (Omniflow II) in femoropopliteal position. J Vasc Surg 2020; 71: 1630-1643 DOI: 10.1016/j.jvs.2019.08.234.
• 18 Chang CK, Scali ST, Feezor RJ. et al. Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia. J Vasc Surg 2014; 60: 1554-1564 DOI: 10.1016/j.jvs.2014.06.009.
• 19 Gerhard-Herman MD, Gornik HL, Barrett C. et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135: e686-e725 DOI: 10.1161/CIR.0000000000000470.
• 20 Klinkert P, Schepers A, Burger DH. et al. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg 2003; 37: 149-155 DOI: 10.1067/mva.2002.86.
• 21 Berglund J, Bjorck M, Elfstrom J. Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material. Eur J Vasc Endovasc Surg 2005; 29: 412-418
• 22 Piffaretti G, Dorigo W, Ottavi P. et al. Results of infrainguinal revascularization with bypass surgery using a heparin-bonded graft for disabling intermittent claudication due to femoropopliteal occlusive disease. J Vasc Surg 2019; 70: 166-174 e161 DOI: 10.1016/j.jvs.2018.10.106.
• 23 Ballotta E, Da Giau G, Gruppo M. et al. Revascularization to an isolated (“blind”) popliteal artery segment: a viable procedure for critical limb ischemia. Surgery 2009; 145: 426-434 DOI: 10.1016/j.surg.2008.12.005.
• 24 Farber A, Menard MT, Conte MS. et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N Engl J Med 2022; 387 (25) 2305-2316 DOI: 10.1056/NEJMoa2207899.
• 25 Nierlich P, Enzmann FK, Metzger P. et al. Alternative Venous Conduits for Below Knee Bypass in the Absence of Ipsilateral Great Saphenous Vein. Eur J Vasc Endovasc Surg 2020; 60: 403-409 DOI: 10.1016/j.ejvs.2020.06.016.
• 26 Albers M, Romiti M, Brochado-Neto FC. et al. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg 2006; 43: 498-503
• 27 Saarinen E, Kauhanen P, Soderstrom M. et al. Long-term Results of Inframalleolar Bypass for Critical Limb Ischaemia. Eur J Vasc Endovasc Surg 2016; 52: 815-822 DOI: 10.1016/j.ejvs.2016.08.051.
• 28 Kodama A, Kobayashi T, Guntani A. et al. Comparison of clinical outcomes, including the wound healing rate, between inframalleolar bypass to the pedal artery and that to the pedal branch artery in the modern endovascular era. J Vasc Surg 2022; 75: 2019-2029 e2012 DOI: 10.1016/j.jvs.2022.01.138.
• 29 Kobayashi T, Hamamoto M, Okazaki T. et al. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia. Vascular 2021; 29: 905-912 DOI: 10.1177/1708538120981224.
• 30 Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. The Joint Vascular Research Group. J Vasc Surg 1997; 26: 543-550
• 31 Uhl C, Hock C, Betz T. et al. Comparison of venous and HePTFE tibial and peroneal bypasses in critical limb ischemia patients unsuitable for endovascular revascularization. Vascular 2015; 23: 607-613 DOI: 10.1177/1708538114568701.
• 32 Neufang A, Dorweiler B, Espinola-Klein C. et al. Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J Vasc Surg 2014; 60: 1543-1553 DOI: 10.1016/j.jvs.2014.07.103.
• 33 Neville RF, Dy B, Singh N. et al. Distal vein patch with an arteriovenous fistula: a viable option for the patient without autogenous conduit and severe distal occlusive disease. J Vasc Surg 2009; 50: 83-88
• 34 Meyer A, Goller K, Horch RE. et al. Results of combined vascular reconstruction and free flap transfer for limb salvage in patients with critical limb ischemia. J Vasc Surg 2015; 61: 1239-1248 DOI: 10.1016/j.jvs.2014.12.005.
• 35 Gifford SM, Fleming MD, Mendes BC. et al. Impact of femoropopliteal endovascular interventions on subsequent open bypass. J Vasc Surg 2016; 64: 623-628 DOI: 10.1016/j.jvs.2016.03.467.
• 36 Enzmann FK, Eder SK, Aschacher T. et al. Tibiodistal vein bypass in critical limb ischemia and its role after unsuccessful tibial angioplasty. J Vasc Surg 2018; 67: 1191-1198 DOI: 10.1016/j.jvs.2017.07.127.
• 37 Ramdon A, Lee D, Hnath JC. et al. Effects of endovascular first strategy on spliced vein bypass outcomes. J Vasc Surg 2020; 71: 880-888 DOI: 10.1016/j.jvs.2019.05.055.
• 38 Santo VJ, Dargon P, Azarbal AF. et al. Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure. J Vasc Surg 2014; 60: 129-135 DOI: 10.1016/j.jvs.2014.01.013.
• 39 Jongsma H, Bekken JA, van Buchem F. et al. Secondary interventions in patients with autologous infrainguinal bypass grafts strongly improve patency rates. J Vasc Surg 2016; 63: 385-390 DOI: 10.1016/j.jvs.2015.08.100.
• 40 Debus ES, Nehler MR, Govsyeyev N. et al. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial. Circulation 2021; 144: 1104-1116 DOI: 10.1161/CIRCULATIONAHA.121.054835.